Hongbing Wang
NIH Rank #2322
- Program Award PI
- R01 Award PI
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8047593Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Pharmacology
NIH Funding · FY2025
Linked Award Amount
$3.7M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#2,322
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Hongbing Wang as a PI. Multi-PI records show the full award amount for context.
- 1R01CA295603-01A1R01Impact of CAR and Nrf2 dual activation on cyclophosphamide bioactivation and doxorubicin detoxification$2.8Maward amount
- 5U01FD008322-02U01Comprehensive assessment of the diastereomer composition of LEQVIO (Inclisiran) to determine how chemical synthesis impacts biological activity$499.9Kaward amount
- $398Kaward amount
Award organization
Organizations that administered FY2025 awards listing Hongbing Wang as a PI.
FY2025 award administered by University of Maryland Baltimore (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024ScienceDex Coverage BeginsEarliest loaded PI award records: FY2024
- 2024$500K Cumulative Linked Award Amount
- 2024R01 Award Record
- 2025$1M Cumulative Linked Award Amount
- 2025$2M Cumulative Linked Award Amount
- 2025Reached Top 50% by Award-Linked RankRanked #2322
- 2025Reached Top 25% by Award-Linked RankRanked #2322
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Hongbing Wang.